Data from A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib Plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
crossref(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined